Advancements in Early Cancer Detection: Toward Integrated, Longitudinal Precision Screening

Early cancer detection has historically relied on episodic, population-based screening strategies interpreted against fixed thresholds. Although effective in selected contexts, such approaches detect disease primarily after structural or biochemical abnormalities become overt. Advances in genomics, liquid biopsy, and metabolomics now permit a conceptual transition from static screening toward longitudinal, biologically calibrated surveillance. This review proposes an integrated early-detection architecture grounded in four complementary dimensions of tumorigenesis: inherited susceptibility, somatic field evolution, molecular residual disease, and functional metabolic remodeling. Germline variants establish life-course risk and recalibrate surveillance intensity. Somatic mutational signatures and field cancerization describe spatial conditioning of tissues long before overt malignancy. Circulating tumor DNA (ctDNA) provides temporal resolution by tracking clonal persistence after therapy. Extending this framework, emerging evidence from microbiome and metabolomic studies supports the hypothesis that sustained alterations in volatile organic compound (VOC) profiles may reflect early tumor–microbiome ecosystem shifts. Although a comprehensive wearable multi-gas detection device is not yet clinically available, current technological advances render continuous “volatomics” biologically plausible and conceptually aligned with trajectory-based monitoring. Rather than advocating a single transformative assay, this manuscript argues for convergence: longitudinal biomarker baselines, germline priors, tumor-informed molecular templates, ctDNA dynamics, and prospective metabolic sensing integrated within a calibrated decision system. Such a platform would function not as a replacement for established diagnostic tools, but as a stratified triage architecture capable of identifying sustained biological deviation warranting further evaluation. Early detection, in this reframed paradigm, becomes a dynamic process of recognizing evolving biological drift rather than a binary event triggered by threshold crossing.